A pioneering ultrasound treatment for liver cancer has debuted at Addenbrookes Hospital, offering a non-surgical option to destroy neoplasm tissue effectively.
- Addenbrookes Hospital in Cambridge is the first in Europe to provide the focused ultrasound treatment for liver cancer, known as histotripsy, outside of clinical trials.
- The innovative procedure employs ultrasound waves to create microscopic bubbles in tumor tissue, which collapse rapidly to destroy cancer cells without invasive surgery.
- The treatment takes just 30 minutes and represents a significant advancement in the National Health Services approach to managing liver cancer, reducing patient recovery time.
Why It Matters
This breakthrough in treating liver cancer highlights a shift towards non-invasive therapies in oncology, potentially improving patient outcomes and reflecting ongoing advancements in medical technology and treatment methodologies.